ClinicalTrials.Veeva

Menu

Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis

N

Nanjing University School of Medicine

Status

Unknown

Conditions

Organ Failure, Multiple
Acute Pancreatitis

Study type

Observational

Funder types

Other

Identifiers

NCT03282253
ESCDEPDSSAP

Details and patient eligibility

About

In this study, the investgatiors aimed to investigate the associations between serum levels of stearoyl-CoA desaturase-1(SCD-1) and the disease severity as well as the presence of adverse clinical events, such as local complications, organ failure, mortality and so on.In this prospective study, participants were divided into two groups based on serum SCD-1 concentration on admission and prospectively observe the disease severity and clinical outcomes of them.

Enrollment

216 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Diagnosis of acute pancreatitis (Atlanta standard), abdominal pain occurred within one week of admission;
  2. APACHEII score is more than 8 and Ranson score is greater than 3;
  3. Age 18-75;
  4. Obtaining informed consent.

Exclusion criteria

  1. Pregnancy pancreatitis;
  2. Patients with the following disease history: severe cardiac, pulmonary, renal, liver function insufficiency or immunodeficiency disease.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems